Endoscopy 2007; 39(7): 647-649
DOI: 10.1055/s-2007-966638
Editorial

© Georg Thieme Verlag KG Stuttgart · New York

Low-grade dysplasia in Barrett’s esophagus - an innocent bystander? Contra

Low-grade intraepithelial neoplasia in the gastrointestinal tractM.  Vieth1
  • 1Institute of Pathology, Klinikum Bayreuth, Bayreuth, Germany
Further Information

Publication History

Publication Date:
05 July 2007 (online)

According to recent guidelines, the diagnosis of low-grade intraepithelial neoplasia (formerly known as ”low-grade dysplasia”, abbreviated to ”LGD”) in Barrett’s esophagus requires a more frequent surveillance program, examining patients until the histology is negative for neoplasia or until a higher degree of neoplasia is detected [1] [2]. This is rather difficult to understand because the guidelines for managing this condition in the colon, duodenum, and stomach advise gastroenterologists to remove foci of low-grade intraepithelial neoplasia (i. e. adenomas) completely rather than to wait for the lesion to disappear or progress (which would be regarded as a rather lazy, or at least an unethical attitude with respect to such lesions in these sites).

References

  • 1 British Society of Gastroenterology .Guidelines for the diagnosis and management of Barrett’s columnar-lined oesophagus. 2005. Available from: URL: http://www.bsg.org.uk/
  • 2 Sampliner R E. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett’s esophagus.  Am J Gastroenterol. 2002;  97 1888-1895
  • 3 Vieth M, Kiesslich R. Distinction of high-grade intraepithelial neoplasia and invasive Barrett’s adenocarcinoma.  Esophagus. 2006;  3 171-176
  • 4 Schnell T G, Sontag S J, Chejfec G. et al . Long-term nonsurgical management of Barrett’s esophagus with high-grade dysplasia.  Gastroenterology. 2001;  120 1607-1619
  • 5 Sharma P, Weston A P, Topalovski M. et al . Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett’s oesophagus.  Gut. 2003;  52 24-27
  • 6 Sharma P, Marcon N, Wani S. et al . Non-biopsy detection of intestinal metaplasia and dysplasia in Barrett’s esophagus: a prospective multicenter study.  Endoscopy. 2006;  38 1206-1212
  • 7 Egger K, Meining A, Werner M. et al . Biopsy surveillance is still necessary in patients with Barrett’s oesophagus despite new endoscopic imaging techniques.  Gut. 2003;  52 18-23
  • 8 O’Connor J B, Falk G W, Richter J E. The incidence of adenocarcinoma and dysplasia in Barrett’s esophagus: report on the Cleveland Clinic Barrett’s Esophagus Registry.  Am J Gastroenterol. 1999;  94 2037-2042
  • 9 Csendes A, Smok G, Burdiles P. et al . Prevalence of intestinal metaplasia according to the length of the specialized columnar epithelium lining the distal esophagus in patients with gastroesophageal reflux.  Dis Esophagus. 2003;  16 24-28
  • 10 Gopal D V, Lieberman D A, Magaret N. et al . Risk factors for dysplasia in patients with Barrett’s esophagus (BE): results from a multicenter consortium.  Dig Dis Sci. 2003;  48 1537-1541
  • 11 Conio M, Blanchi S, Lapertosa G. et al . Long-term endoscopic surveillance of patients with Barrett’s esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study.  Am J Gastroenterol. 2003;  98 1931-1939
  • 12 Vieth M, Stolte M. Barrett’s esophagus and neoplasia: data from the Bayreuth Barrett’s archive.  Gastroenterology. 2002;  122 590-591
  • 13 Montgomery E, Bronner M P, Goldblum J R. et al . Reproducibility of the diagnosis of dysplasia in Barrett’s esophagus: a reaffirmation.  Hum Pathol. 2001;  32 368-378
  • 14 Skacel M, Petras R E, Gramlich T L. et al . The diagnosis of low-grade dysplasia in Barrett’s esophagus and its implications for disease progression.  Am J Gastroenterol. 2000;  95 3383-3387
  • 15 Weston A P, Badr A S, Hassanein R S. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett’s multifocal high-grade dysplasia or adenocarcinoma.  Am J Gastroenterol. 1999;  94 3413-3419
  • 16 Sharma P, Falk G W, Westen A P. et al . Dysplasia and cancer in a large multicenter cohort of patients with Barrett’s esophagus.  Clin Gastroenterol Hepatol. 2006;  4 566-572
  • 17 Lim C H, Treanor D, Dixon M F, Axon A TR. Low-grade dysplasia in Barrett’s esophagus has a high risk of progression.  Endoscopy. 2007;  39 581-587
  • 18 Vieth M, Schubert B, Lang-Schwarz K. et al . Frequency of Barrett’s neoplasia after initial negative endoscopy with biopsy: a long-term histopathological follow-up study.  Endoscopy. 2006;  38 1201-1205
  • 19 Sharma P, Dent J, Armstrong D. et al . The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria.  Gastroenterology. 2006;  131 1392-1399
  • 20 Spechler S J. Clinical practice: Barrett’s esophagus.  N Engl J Med. 2002;  346 836-842
  • 21 Pech O, Vieth M, Schmitz D. et al . Conclusions from the histological diagnosis of low-grade intraepithelial neoplasia in Barrett’s oesophagus.  Scand J Gastroenterol. 2007;  42 682-688

M. Vieth, MD

Institute of Pathology

Klinikum Bayreuth

Preuschwitzer Str. 101

95445 Bayreuth

Germany

Fax: +49-921-400-5609

Email: vieth.lkpathol@uni-bayreuth.de

    >